Pragmatic Trial of Psilocybin Therapy in Palliative Care
Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the
efficacy and safety of psilocybin therapy compared to an active control in treating
demoralization in adults near the end of life (≤2 years life expectancy).